Debt-to-equity of Senti Biosciences, Inc. from 31 Dec 2021 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Senti Biosciences, Inc. quarterly Debt-to-equity in % history and change rate from 31 Dec 2021 to 30 Sep 2025.
  • Senti Biosciences, Inc. Debt-to-equity for the quarter ending 30 Sep 2025 was 187%, a 87% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Senti Biosciences, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 187% +87% +87% 30 Sep 2025
Q2 2025 171% +94% +124% 30 Jun 2025
Q1 2025 143% +79% +124% 31 Mar 2025
Q4 2024 125% +71% +129% 31 Dec 2024
Q3 2024 100% +53% +112% 30 Sep 2024
Q2 2024 76% +35% +83% 30 Jun 2024
Q1 2024 64% +26% +71% 31 Mar 2024
Q4 2023 55% +0.77% +1.4% 31 Dec 2023
Q3 2023 47% -189% -80% 30 Sep 2023
Q2 2023 41% +99% 30 Jun 2023
Q1 2023 37% +52% 31 Mar 2023
Q4 2022 54% +68% 31 Dec 2022
Q3 2022 236% 30 Sep 2022
Q2 2022 -58% 30 Jun 2022
Q1 2022 -15% 31 Mar 2022
Q4 2021 -14% 31 Dec 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.